Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Journal of Medicinal Chemistry|July 23, 2011
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase BElias Maccioni, Stefano Alcaro, Roberto Cirilli, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida sppFranco Chimenti, Bruna Bizzarri, Elias Maccioni, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|October 27, 2018
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitorsSerena Massari, Angela Corona, Simona Distinto, et al.Plos One|January 23, 2016
Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6Angela Corona, Rita Meleddu, Francesca Esposito, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 19, 2021
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivativesRita Meleddu, Serenella Deplano, Elias Maccioni, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 18, 2020
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluationBenedetta Fois, Simona Distinto, Rita Meleddu, et al.Journal of Natural Products|April 19, 2019
Ferulic Acid Esters and Withanolides: In Search of Withania somnifera GABAA Receptor ModulatorsVijay P Sonar, Benedetta Fois, Simona Distinto, et al.European Journal of Medicinal Chemistry|December 31, 2015
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffoldSimona Distinto, Rita Meleddu, Matilde Yanez, et al.Viruses|July 10, 2020
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant VariantsAngela Corona, Ester Ballana, Simona Distinto, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 22, 2019
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrasesSimona Distinto, Rita Meleddu, Francesco Ortuso, et al.Pageof 7